Blanter J, Baldwin E, Patel R, Sheng T, et al. Patterns in use and tolerance of adjuvant neratinib in patients with hormone
receptor (HR)-positive, HER2-positive early-stage breast cancer. Breast Cancer Res Treat 2024 Aug 17. doi: 10.1007/s10549-024-07461.
PMID: 39153126
|